Martin Skov

4PUBLICATIONS
25CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 13, 2024
Neuromuscular transmission deficits in patients with CMT and ClC-1 inhibition in CMT animal models.

Thomas Skjærlund Grønnebæk, Helga Haahr-Lillevang, Martin Skov

|Oct 29, 2024
ClC-1 Inhibition as a Mechanism for Accelerating Skeletal Muscle Recovery After Neuromuscular Block in Rats.

Marianne Skals, Martin Broch-Lips, Martin Brandhøj Skov

|Mar 20, 2024
The ClC-1 chloride channel inhibitor NMD670 improves skeletal muscle function in rat models and patients with myasthenia gravis.

Martin Skov, Titia Q Ruijs, Thomas S Grønnebæk

|Dec 13, 2016
Trojan triplets: RNA-based pathomechanisms for muscle dysfunction in Huntington's disease.

Martin Skov, Robert T Dirksen

Pageof 1